Václav Havel (Vaclav Havel)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Structure Activity Relationship

Electron Microscopy

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Václav Havel, Andrew C Kruegel, Benjamin Bechand, Scot McIntosh, Leia Stallings, Alana Hodges, Madalee G Wulf, Mel Nelson, Amanda Hunkele, Michael Ansonoff, John E Pintar, Christopher Hwu, Rohini S Ople, Najah Abi-Gerges, Saheem A Zaidi, Vsevolod Katritch, Mu Yang, Jonathan A Javitch, Susruta Majumdar, Scott E Hemby, Dalibor Sames
Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models. Nature communications 15 (1) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature (2024)
Srijita Bhowmik, Juraj Galeta, Václav Havel, Melissa Nelson, Abdelfattah Faouzi, Benjamin Bechand, Mike Ansonoff, Tomas Fiala, Amanda Hunkele, Andrew C Kruegel, John E Pintar, Susruta Majumdar, Jonathan A Javitch, Dalibor Sames
Site selective C-H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy. Nature communications 12 (1) (2021)